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Abstract
Sinonasal inverted papilloma (IP) is the most common benign epithelial tumor in the nasal cavity and paranasal sinuses, with a
worldwide incidence between 0.6 and 1.5/100 000 persons per year. However, only a few studies have investigated patient-
dependent factors related to IP recurrence and persistence. According to available evidence, these factors are still debated, and
results are contradictory. In this multicenter retrospective study, we analyzed the clinical records of 130 patients who were
surgically treated for sinonasal IP to evaluate the factors affecting recurrence and persistence of IP and compared the curative
rates of different surgical approaches. Our analysis showed that IP recurrence is strongly related to specific risk factors including
incomplete surgical removal, stage of disease, site of the lesion, surgical technique, and malignancy rate. In conclusion, the
recurrence of IP may be affected by several risk factors; these factors must be carefully considered during clinical evaluation and
especially during the follow-up of patients with IP.
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Introduction
Sinonasal inverted papilloma (IP), first described in 1854, is a
benign epithelial lesion of the nasal cavity and paranasal
sinuses; its incidence ranges between 0.6 and 1.5/100 000 per-
sons per year.1-4 IP mainly occurs in adults during the fifth
decade of life, with a higher prevalence in males (male to
female ratio: 7:1) 5 and in the Caucasian race.6,7 IP is the most
common histological type of nasal papilloma, followed by
oncocytic papilloma and fungiform papilloma.8 IP arises in the
Schneiderian epithelium of the nasal cavity and paranasal
sinuses, primarily from the lateral nasal wall, and is generally
unilateral.1-4 Three characteristics make IP different from other
sinonasal tumors: the high recurrence rate (up to 70%), strong
potential for local bone erosion, and risk of malignant trans-
formation (5%-13%).3 Etiology of IP remains mostly
unknown; an association with human papilloma virus (HPV),
especially HPV types 6, 11, 16, and 18, has been reported in up
to 40% of cases 9, but the literature remains contradictory.10,11
Clinical nonspecific symptoms of IP may include unilateral
occlusion, rhinorrhea, sinus infection, and hyposmia/anosmia.
Such primary manifestations may be accompanied by head-
aches and facial pain/pressure, lacrimation, or impaired
vision.5 Endoscopically, the lesion appears as a grayish poly-
poid mass with a multinodular surface.3 The treatment of
choice is surgical; a purely endoscopic endonasal approach or
combined endoscopic and external approach has now become
the gold standard for many authors.12-17 Chemotherapy and/or
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radiation therapy may follow surgery in case of malignant
transformation; many authors have suggested that radiotherapy
could be used for patients whose tumor has not been com-
pletely resected or in case of multiple recurrences.18,19
Several factors with a potential role in the recurrence or
persistence of IP have been described, including cigarette
smoke, allergy, certain occupational exposures, demographic
factors, histology, lesion side, stage, and surgical approach;
however, their role is still controversial and a specific cause
has yet to be confirmed.11 The aim of this multicenter retro-
spective study is to analyze the factors affecting the recurrence
and persistence of sinonasal IP.
Patients and Methods
One-hundred thirty patients diagnosed with sinonasal IP at the
Policlinico Umberto I of Rome and Ospedale Niguarda ‘‘Ca
Granda’’ of Milan, Italy, from December 2004 to January 2016,
were included in the study.
Full clinical information including age and gender, smoking
history, comorbidities, endoscopic examination results, follow-
up appointments, and computed tomography (CT) or magnetic
resonance imaging (MRI) evidence were available for all
patients. Preoperative CT scans and MRI were evaluated to
identify the localization of the lesion and the involved sinuses
and to differentiate between sinus involvement by tumor or by
secretion in extensive disease. Using this modality, all patients
were classified according to Krouse6 and Dragonetti-Minni20
staging (Table 1).
All patients were treated with endoscopic approach or com-
bined endoscopic/open approach (midfacial degloving
approach, frontal osteoplastic or lateral rhinotomy approach).
After debulking of the lesion, the attachment sites of the tumor
were identified, removing only the disease mucosae and pre-
serving healthy tissues. Intraoperative biopsy was used to iden-
tify resection margins. The surgical approach was tailored to
preoperative imaging findings and modified according to
intraoperative findings. The goal of surgical resection was
tumor debulking followed by complete tumor removal.3,11
The primary outcome measure was the incidence of persis-
tence or recurrence of IP in our sample; persistence was defined
as the presence of disease <6 months from surgery, persistence
was defined as the presence of disease >6 months from surgery.
Secondary outcome measures were the frequency of negative
events, such as surgical complications and death. Recurrence
rates and intervals between surgical treatment and first recur-
rence, according to surgical methods and risk factors, were
analyzed. Averaging + standard deviation, w2 test, Student t
test, Kaplan-Meier estimator, and Cox proportional hazards




One-hundred thirty patients were diagnosed with sinonasal IP;
all patients were of Caucasian race. The group was composed
of 89 (66.9%) males and 41 (30.8%) females (ratio: 2.17:1);
age ranged from 21 to 89 years (average: 60.7 years, standard
deviation [SD] ¼ 17.28). The average duration of follow-up
was 60 months (36-104 months, SD ¼ 19.28).
Recurrence of the disease was found in 12 (9.2%) patients (7
males and 5 females, average age 58.3 years, range 21-79 years,
SD ¼ 15.67); recurrence was found in 6 (4.6%) cases (4 males
and 2 females, average age 56.9 years, range 28-75 years, SD ¼
16.70). No statistically significant effect on recurrence or persis-
tence rates was found for sex (P ¼ .460 and P ¼ .872, respec-
tively) and age (P ¼ .634 and P ¼ .542, respectively).
Fourteen (10.8%) patients died during follow-up; 4 (3.1%)
died for IP sequelae and 10 (7.7%) for other causes not related
to the sinonasal disease. Patients who died for the sinonasal
disease were significantly younger than those who died for
other causes (Mann-Whitney test, P ¼ .001).
Table 1. Krouse (2000) and Dragonetti-Minni (2008) Staging Systems for Inverted Papilloma.
Krouse (2000) Dragonetti-Minni (2008)
T1: Confined to the nasal cavity Type I: Isolated tumor involving one site in the nasal fossa. It may originate from the nasal septum,
anterior ethmoid, posterior ethmoid, medial turbinate, frontal recess or sphenoethmoidal recess
T2: Ostiomeatal complex, ethmoid sinuses,
medial portion of the maxillary sinus (with
or without involvement of the nasal cavity)
Type II: The sphenoid is the primary location
T3: Any wall of the maxillary sinus, sphenoid
sinus, frontal sinus (with or without T2
criteria)
Type III: All the previous sites with an initial involvement of the maxillary sinus medial wall
T4: Any extranasal/extrasinus extension or
malignancy
Type IV
Type IVa: Tumor projecting into the maxillary sinus without involving the anterior wall
Type IVb: Tumor extending to the anterior and/or inferior wall of the maxillary sinus
Type V: Tumor extending to the median portion of the frontal sinus. The tumor extends to the
frontal sinus but only goes as far as halfway into the orbital roof
Type VI: Extension to the lateral portion of the frontal sinus or with extranasal extension to soft
tissues without periorbital and/or ductal and/or neighboring (ie, intracranial) extraparanasal
tissue infiltration
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Risk Factors
Figure 1 shows the prevalence of known risk factors in the
study sample. Almost half (46.2%) of the enrolled patients had
a history of cigarette smoking. Between the 12 cases with
recurrence of disease, 8 (66.7%) were smokers (P ¼ .038, Cox
model). Contrarily, no statistically significant differences were
found between smokers and nonsmokers who had a persistence
of the disease (P ¼ .541, Cox model). Smoking influenced
overall survival over time (P¼ .019, t test); among the patients
who died during follow-up, 80% were smokers (P ¼ .015).
Twenty-six (20%) patients had a history of exposure to
known or suspected occupational factors for sinonasal cancer
(wood and leather industry, textile industry, and metalwork-
ing). No significant differences were found regarding the fre-
quency of recurrence and persistence among patients with and
without exposure to occupational risk factors (P ¼ .632 and P
¼ .119, respectively). Mortality was higher in patients with
history of exposure to occupational risk factors (P ¼ .011).
Histology
In the present study, 115 (88.5%) patients had a definitive
pathological diagnosis of IP, 4 (3.1%) had a diagnosis of IP
associated with severe cellular dysplasia, 7 (5.4%) had a diag-
nosis of IP associated with moderate dysplasia, while 4 (3.1%)
had a diagnosis of squamous cell carcinoma (SCC) in IP (Fig-
ure 2). In the latter cases, SCC was already present with the IP
(synchronous tumors). During the follow-up, none of the
remaining 126 patients developed a malignant tumor (meta-
chronous tumor).
Cox regression analysis showed a significant correlation
between recurrence rate and histology. Patients with IP and
dysplasia had a higher recurrence rate compared to those with
IP alone (P ¼ .038; hazard ratio ¼ 2.405); no correlation was
found between histology (dysplasia) and persistence of disease
(P ¼ >.05).
Patients diagnosed with SCC had a lower survival rate (P <
.001). The disease-specific survival for IP alone, dysplasia-
associated IP, and IP associated with carcinoma was 100%,
100%, and 50%, respectively.
Lesion Side
Sixty-three (48.5%) patients developed sinonasal IP in the right
side, 67 (51.5%) in the left side. The lesion site did not show a
significant correlation to recurrence (P ¼ .918) nor to persis-
tence (P ¼ .957; Figure 3).
Figure 4 details the tumor location in our sample. The max-
illary sinus was involved in 54 (41.5%) cases, the anterior
ethmoid sinus in 44 (33.8%) cases, the frontal sinus was
involved in 21 (16.2%) cases, and the sphenoid sinus in 11
(8.4%) cases. The origin of IP significantly influenced the fre-
quency of persistence and recurrence of the disease: 7 (58.3%)
of the 12 recurrences developed in patients with sinonasal IP
located in the anterior wall of the maxillary sinus; 3 (25%)
occurred in patients with tumor located in the frontal sinus; 1
(8.3%) in the anterior ethmoid sinus and 1 (8.3%) in the lateral
wall of the maxillary sinus. These differences were significant
(Cox regression, P ¼ .045). The persistence of the tumor was
also related to its origin (P ¼ .009); in 2 (33.3%) of the 6
patients who had disease persistence, the site of origin of the
tumor was located at the level of the upper wall of the maxillary
Figure 1. Prevalence of smoking and occupational factors for sino-
nasal cancer such as wood- and leather-related occupations, textile
industry, and metalworking in the study sample.
Figure 2. Definitive pathological findings in the patients included in
the study.
Figure 3. Tumor side in the study sample.
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sinus. Contrarily, the tumor origin did not influence survival
(P ¼ .638 for death in general, P ¼ .554 for death from other
causes, P ¼ .461 for death due to the sinonasal condition).
Stage
Patients were classified according to the Krouse and
Dragonetti-Minni classifications. Tumor staging according to
the Krouse classification was not statistically significant for
primary outcome (P ¼ .431 for recurrence, P ¼ .343 for per-
sistence), while staging according to the Dragonetti-Minni
classification was significant for the development of recurrence
(P ¼ .045), but not for the other outcomes.
Surgical Approach
All patients included in the study were treated with endo-
scopic approach based on ethmoidal subperiosteal resection
(ESR) associated with sphenoidotomy, maxillary antrostomy,
and frontal sinus recess opening, with possible dissection of
other sinuses according to the extension and the origin of the
tumor. Twenty-five (19.2%) cases were treated with ESR; 11
(8.5%) cases with ESR associated with sphenoidectomy with
drilling of the anterior and inferior wall of the sphenoid; in 15
(11.5%) patients, an ESR associated with extended medial
antrostomy was performed; 11 (8.5%) cases were treated with
ESR and endoscopic maxillectomy; 45 (34.6%) cases with
ESR associated with anterior maxillectomy with (18.6%) or
without (16%) nasolacrimal duct resection; finally, 23
(17.7%) patients were treated with ESR associated with fron-
tal sinusotomy according to Draf type II (9.8%) or Draf type
III (7.9%; Figure 5).
A statistically significant difference between recurrence and
persistence rates was found for each approach (P ¼ .048 and P
¼ .045). In particular, patients who underwent ESR alone had a
higher risk of tumor persistence, while the patients treated with
ESR combined with anterior maxillectomy had a higher risk to
develop a recurrence. The nasolacrimal duct resection had a
significant effect on recurrence rates: Only 1 patient who
underwent nasolacrimal duct resection developed a recurrence,
while 5 patients with no nasolacrimal duct resection developed
a recurrence.
The surgical approach did not influence the survival rate in
our sample; Cox regression analysis showed a P value of .834,
.542, and .231, respectively, for death, death due to other
causes, and death due to the sinonasal condition.
Complications occurred in 24 (18.5%) patients. Minor com-
plications occurred in 12 (9.2%) patients: epiphora in 7 (58.3%)
patients, epistaxis in 3 (25%) cases, and periorbital edema in 2
(16.7%) cases. Major complications occurred in 10 (7.7%)
patients; 3 (30%) had a rhino-liquoral fistula, 4 (40%) cases a
frontal mucocele, and 3 (30%) cases a lacrimal duct stenosis.
The development of complications had no effect on primary
outcomes (P ¼ .341 for persistence and P ¼ .341 for recur-
rence; Figure 6).
Intraoperative positive margins were found in 34 (26.1%)
cases; this required an immediate enlargement of the surgical
exeresis within the same surgical procedure. The risk of
Figure 4. Tumor location in our sample. The maxillary sinus was the
most involved, followed by the ethmoid sinus, the frontal sinus, and
the sphenoid sinus. Circles () indicate the number of recurrences that
developed in our sample, sorted by location.
Figure 5. Surgical approach performed in the patients included in the
study. All patients were treated with endoscopic approach based on
ethmoidal subperiostal resection (ESR) associated with sphenoidot-
omy, maxillary antrostomy, and frontal sinus recess opening, with
possible dissection of other sinuses according to the extension and the
origin of the tumor.
Figure 6. Minor and major complications occurred in our sample.
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recurrence and persistence of IP in our sample was not influ-
enced by the presence of intraoperative positive margins.
Discussion
Recent meta-analyses have shown a recurrence rate of sinona-
sal IP between 15% and 20%21,22; however, there is still much
controversy on the entity and role of the factors involved in IP
recurrence. The aim of this multicenter retrospective study was
to analyze the factors affecting the recurrence and persistence
of sinonasal IP.
It is well known that IP develops more frequently in men
than in women23; in our sample, gender did not seem to be
related to the recurrence rate, as well as age.
Among the 130 patients included in the study, almost half of
them had a history of smoking; we found that smoking was
significantly associated with recurrence. These data are consis-
tent with what reported by Diaz Molina et al on a review of 61
patients with IP.24 The present study also revealed a significant
association between occupational exposure to risk factors, espe-
cially wood- and leather-related industries, textile industry, and
metalworking, and IP; this is consistent with the findings
reported by D’Errico et al.25 In contrast, exposure to risk factors
did not appear to play a role in therapeutic failure in our
patients. This may depend on the characteristics of the sample;
in fact, more than half of the patients with a history of occupa-
tional exposure were no longer actively employed at the time of
the first diagnosis. Therefore, it is possible that the pathogenic
role of these factors decreases upon termination of exposure.
Several studies tried to define histological parameters that
could help predicting multiple recurrence such as malignant
transformation.7 According to the European Position Paper of
endoscopic management of IP, the incidence of dysplasia based
on current literature is 1.9%26; this is significantly lower than
our findings (9%). In our sample, patients with IP associated
with moderate or severe dysplasia had a higher rate of recur-
rence compared to those with no dysplasia.
We found no statistically significant difference in recur-
rence rates according to Krouse stage, while we found a pre-
dictive role using the Dragonetti-Minni classification. The
former only considers the origin of the tumor, not its extension;
this may explain the low predictive value. Instead, the classi-
fication proposed by Dragonetti-Minni20 appears more com-
plete and exhaustive; moreover, it seems to have a better
prognostic value on the risk of recurrence.
The side was not significantly related to a higher rate of
recurrence or persistence in our sample, while lesion localiza-
tion was significantly correlated with recurrence and persis-
tence. Indeed, 7 (58.3%) cases of recurrence developed in
patients with IP in the anterior maxillary sinus wall; in 3
(25%) cases, IP was in the frontal sinus. This finding may be
explained by the surgical difficulty to completely remove the
lesion in these anatomical sites.14,27-30 The elevate frequency
of recurrence and persistence of disease in patients with an IP
in the anterior wall of the maxillary sinus or in the frontal
recess may depend on the difficulty of endoscopically approach
these areas. Finally, history of previous sinonasal surgery rep-
resented an important risk factor for IP recurrence.
Based on our data, the site of origin, extension, presence of
dysplasia, and previous endoscopic-only surgery can lead to an
increased risk of recurrence, estimated at around 6 times
greater than for patients without these characteristics. These
results support the theory that an incomplete initial resection
may lead to an increased likelihood for recurrence after a sec-
ond resection, emphasizing the importance of a complete rad-
ical resection of IP during the first surgery.8,31
This study has some limitations. Being a multicenter study,
surgery was performed by different surgeons. Although the
surgeons involved in the study had a comparable level of expe-
rience (more than 20 years of experience), some surgical dif-
ferences may be present in our sample. The study showed a
significant association between occupational exposure to risk
factors and IP; however, exposure to risk factors did not appear
to play a role in therapeutic failure in our patients. This may
depend on the fact that more than half of the patients with a
history of occupational exposure were no longer actively
employed at the time of the first diagnosis.
In conclusion, our analysis of the cumulative risk of recur-
rence and persistence of IP has shown that 3 of the 4 risk factors
of recurrence mainly depend on the localization of the tumor
and on the surgical approach; contrarily, some factors did not
seem to be related to the surgeon’s ability, such as the presence
of cell dysplasia. These elements must be carefully considered
during clinical evaluation and especially during the follow-up
visits of patients with a diagnosis of IP.
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